動物用医薬品市場：タイプ別、投与経路別、用途別、エンドユーザー別-2025-2030年の世界予測

動物用医薬品市場は、2023年に580億7,000万米ドルと評価され、2024年には629億9,000万米ドルに達すると予測され、CAGR 8.61％で成長し、2030年には1,035億7,000万米ドルに達すると予測されています。

動物用医薬品市場には、家畜、ペット、野生動物など、動物の健康と幸福のために特別に設計された製品が含まれます。この市場には、ワクチン、抗生物質、抗寄生虫薬、薬用飼料添加物など、さまざまな製品が含まれます。動物用医薬品の必要性は、家畜製品の需要の高まり、ペット飼育の増加、人獣共通感染症の管理の必要性によって強調されています。主な用途としては、動物の疾病予防、治療、成長促進などがあり、食の安全、公衆衛生、消費者の安全に直接影響を与えます。最終用途分野は、動物病院、農場、ペット病院、動物研究機関など多岐にわたる。成長要因としては、家畜生産の強化、ペット同伴の急増、技術の進歩、動物疾病発生の増加などが挙げられます。新規かつ効率的な薬剤の開発、ドラッグデリバリー・システムの革新、天然・有機の畜産物への嗜好の高まりなどが好機となります。消費者の需要が持続可能で健康志向のソリューションに傾いていることから、企業はバイオ医薬品と栄養補助食品に注力することが勧められます。課題としては、厳しい規制基準、研究開発費の高騰、薬剤耐性株の出現などがあり、市場拡大を阻害する可能性があります。さらに、動物福祉や抗生物質の過剰使用に関する倫理的な懸念も大きなハードルとなっています。技術革新が必要な分野としては、プロバイオティクスやプレバイオティクスといった抗生物質の代替品の開発、ワクチンの効能強化、個別化動物ヘルスケアに向けたデータ分析の活用などが挙げられます。また、動物用遠隔医療やAIを活用した疾病診断ツールのようなデジタルヘルスケアソリューションを重視することも、事業の成長を促進する可能性があります。市場は競合情勢にあり、規制による圧力と、進化する動物医療の課題に対処するための絶え間ないイノベーションの必要性によってダイナミックに動いており、戦略的敏捷性と継続的な研究投資が必要な複雑な情勢を意味しています。

市場力学：急速に進化する動物用医薬品市場の主要市場インサイトを公開

動物用医薬品市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 人獣共通感染症および慢性疾患の増加によるペット飼育の増加
  • 家畜の大幅な増加
  • 政府による投薬やワクチン接種の義務化
• 市場抑制要因
  • ペットの飼い主の認識や教育が限定的であることに伴う動物用医薬品の高コスト
• 市場機会
  • オーガニックおよびナチュラルな動物用医薬品への需要の高まり
  • 個々の動物に合わせた精密医療の台頭の増加
• 市場の課題
  • 畜産農家での過剰使用による抗生物質耐性への懸念の高まり

ポーターのファイブフォース：動物用医薬品市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：動物用医薬品市場における外部からの影響の把握

外部マクロ環境要因は、動物用医薬品市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析動物用医薬品市場における競合情勢の把握

動物用医薬品市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス動物用医薬品市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、動物用医薬品市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨動物用医薬品市場における成功への道筋を描く

動物用医薬品市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ペットの飼育数の増加と人獣共通感染症および慢性疾患の増加
    • 家畜の個体数が著しく増加
    • 政府による強制的な投薬と予防接種の出現
  • 抑制要因
    • 動物用医薬品のコストが高いことと、ペットの飼い主の間での認識と教育が限られていること
  • 機会
    • オーガニックとナチュラルの需要の高まり動物用医薬品
    • 個々の動物に合わせた精密医療の出現が増加
  • 課題
    • 動物農場での過剰使用による抗生物質耐性への懸念の高まり
• 市場セグメンテーション分析
  • タイプ：急性期治療に欠かせない動物用医薬品の使用増加
  • エンドユーザー：獣医クリニック全体での動物用医薬品の使用法の進化
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 動物用医薬品市場：タイプ別

• ワクチン
  • 不活性化（殺された）
  • 修正/減衰ライブ
• 動物用医薬品
  • 鎮痛剤
  • 抗感染薬
  • 抗炎症
  • 寄生虫駆除剤

第7章 動物用医薬品市場：投与経路別

• 注射可能
• オーラル
• 話題

第8章 動物用医薬品市場：用途別

• 水生動物
• コンパニオンアニマル
• 家畜

第9章 動物用医薬品市場：エンドユーザー別

• 病院
• 研究所
• 獣医クリニック

第10章 南北アメリカの動物用医薬品市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の動物用医薬品市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの動物用医薬品市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ゾエティス、米国でボンカットプレガバリン経口液の発売により猫のケアを強化
  • ゾエティスとブラックスミスメディシンズ、耐性菌と闘い動物の健康を向上させる新しい抗生物質の開発で提携
  • メルク社、エランコ社の水産事業を戦略的に買収し、水産養殖部門を強化
• 戦略分析と提言

企業一覧

• Alivira Animal Health Limited
• Aurora Pharmaceutical, Inc.
• Bimeda Holdings PLC
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Dechra Pharmaceuticals PLC
• Elanco Animal Health Incorporated
• Hester Biosciences Limited
• Huvepharma, Inc.
• IDEXX Laboratories, Inc.
• Indian Immunologicals Ltd.
• Merck & Co., Inc.
• Neogen Corp.
• Nippon Zenyaku Kogyo Co., Ltd.
• Norbrook Laboratories
• Nutreco N.V.
• Orion Corporation
• Ourofino Saude Animal
• Perrigo Company plc
• PetIQ, LLC
• Phibro Animal Health Corporation
• Precision Science
• Sanofi-Aventis Groupe S.A.
• Vesper Group
• Vetoquinol S.A.
• Virbac S.A.
• Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. ANIMAL PHARMACEUTICALS MARKET RESEARCH PROCESS
• FIGURE 2. ANIMAL PHARMACEUTICALS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ANIMAL PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. ANIMAL PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ANIMAL PHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ANIMAL PHARMACEUTICALS MARKET DYNAMICS
• TABLE 7. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY INACTIVATED (KILLED), BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY MODIFIED/ ATTENUATED LIVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY AQUATIC ANIMALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERNARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 51. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 52. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 53. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 83. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 84. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 85. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 89. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 90. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 91. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 99. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 105. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 117. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 129. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 141. VIETNAM ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. VIETNAM ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 154. DENMARK ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 155. DENMARK ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 160. EGYPT ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 161. EGYPT ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 166. FINLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 167. FINLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 172. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 173. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 178. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 179. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 184. ISRAEL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 185. ISRAEL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 190. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 191. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 192. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 193. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 194. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 196. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 197. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 202. NIGERIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 203. NIGERIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 208. NORWAY ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 209. NORWAY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 214. POLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 215. POLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 216. POLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 217. POLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 218. POLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 219. POLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 220. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 221. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 222. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 223. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 224. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 225. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 226. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 227. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 232. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 244. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 245. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 250. SWEDEN ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 251. SWEDEN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 256. SWITZERLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 257. SWITZERLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 262. TURKEY ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 263. TURKEY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 268. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 269. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 274. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 275. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 280. ANIMAL PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 281. ANIMAL PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023

The Animal Pharmaceuticals Market was valued at USD 58.07 billion in 2023, expected to reach USD 62.99 billion in 2024, and is projected to grow at a CAGR of 8.61%, to USD 103.57 billion by 2030.

The animal pharmaceuticals market encompasses products designed specifically for the health and well-being of animals, including livestock, pets, and wildlife. This market covers a range of products such as vaccines, antibiotics, antiparasitics, and medicinal feed additives. The necessity of animal pharmaceuticals is underscored by the rising demand for livestock products, increased pet ownership, and the need to manage zoonotic diseases. Key applications include disease prevention, treatment, and growth promotion in animals, which directly impacts food security, public health, and consumer safety. End-use sectors span veterinary clinics, animal farms, pet hospitals, and animal research institutes. Influencing growth factors include the intensification of livestock production, the surge in pet companionship, technological advancements, and increasing incidences of animal disease outbreaks. Opportunities emerge from the development of novel and efficient drugs, innovations in drug delivery systems, and the growing preference for natural and organic animal products. Companies are advised to focus on biopharmaceuticals and nutraceuticals, as consumer demand leans toward sustainable and health-conscious solutions. Challenges include stringent regulatory standards, high R&D costs, and the emergence of drug-resistant strains, which can inhibit market expansion. Additionally, ethical concerns regarding animal welfare and the overuse of antibiotics present significant hurdles. Areas ripe for innovation include the development of alternatives to antibiotics, such as probiotics and prebiotics, enhancing vaccine efficacy, and leveraging data analytics for personalized animal healthcare. Emphasizing digital healthcare solutions like telemedicine for animals and AI-driven disease diagnosis tools can also propel business growth. The market is competitive and dynamic, driven by regulatory pressures and the necessity for constant innovation to address evolving animal health challenges, signifying a complex landscape that necessitates strategic agility and continuous research investments.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Animal Pharmaceuticals Market

The Animal Pharmaceuticals Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising adoption of pets coupled with growing cases of zoonotic and chronic diseases
  • Significant growth experienced in livestock population
  • Emergence of government mandatory medication and vaccinations
• Market Restraints
  • High costs of animal pharmaceuticals along with limited awareness and education among pet owners
• Market Opportunities
  • Growing demand for organic and natural animal pharmaceuticals
  • Increasing emergence of the precision medicine tailored for individual animals
• Market Challenges
  • Increasing concern over antibiotic resistance due to overuse in animal farms

Porter's Five Forces: A Strategic Tool for Navigating the Animal Pharmaceuticals Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Animal Pharmaceuticals Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Animal Pharmaceuticals Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Animal Pharmaceuticals Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Animal Pharmaceuticals Market

A detailed market share analysis in the Animal Pharmaceuticals Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Animal Pharmaceuticals Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Animal Pharmaceuticals Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Animal Pharmaceuticals Market

A strategic analysis of the Animal Pharmaceuticals Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Animal Pharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include Alivira Animal Health Limited, Aurora Pharmaceutical, Inc., Bimeda Holdings PLC, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Hester Biosciences Limited, Huvepharma, Inc., IDEXX Laboratories, Inc., Indian Immunologicals Ltd., Merck & Co., Inc., Neogen Corp., Nippon Zenyaku Kogyo Co., Ltd., Norbrook Laboratories, Nutreco N.V., Orion Corporation, Ourofino Saude Animal, Perrigo Company plc, PetIQ, LLC, Phibro Animal Health Corporation, Precision Science, Sanofi-Aventis Groupe S.A., Vesper Group, Vetoquinol S.A., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Pharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Vaccine and Veterinary Drugs. The Vaccine is further studied across Inactivated (Killed) and Modified/ Attenuated Live. The Veterinary Drugs is further studied across Analgesics, Anti-infectives, Anti-inflammatory, and Parasiticides.
• Based on Route of Administration, market is studied across Injectable, Oral, and Topical.
• Based on Application, market is studied across Aquatic Animals, Companion Animals, and Livestock Animals.
• Based on End User, market is studied across Hospitals, Laboratories, and Veternary Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising adoption of pets coupled with growing cases of zoonotic and chronic diseases
    • 5.1.1.2. Significant growth experienced in livestock population
    • 5.1.1.3. Emergence of government mandatory medication and vaccinations
  • 5.1.2. Restraints
    • 5.1.2.1. High costs of animal pharmaceuticals along with limited awareness and education among pet owners
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing demand for organic and natural animal pharmaceuticals
    • 5.1.3.2. Increasing emergence of the precision medicine tailored for individual animals
  • 5.1.4. Challenges
    • 5.1.4.1. Increasing concern over antibiotic resistance due to overuse in animal farms
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Increasing usage of veterinary drugs indispensable for acute treatments
  • 5.2.2. End User: Evolving usage of the animal pharmaceuticals across the veterinary clinics
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Animal Pharmaceuticals Market, by Type

• 6.1. Introduction
• 6.2. Vaccine
  • 6.2.1. Inactivated (Killed)
  • 6.2.2. Modified/ Attenuated Live
• 6.3. Veterinary Drugs
  • 6.3.1. Analgesics
  • 6.3.2. Anti-infectives
  • 6.3.3. Anti-inflammatory
  • 6.3.4. Parasiticides

7. Animal Pharmaceuticals Market, by Route of Administration

• 7.1. Introduction
• 7.2. Injectable
• 7.3. Oral
• 7.4. Topical

8. Animal Pharmaceuticals Market, by Application

• 8.1. Introduction
• 8.2. Aquatic Animals
• 8.3. Companion Animals
• 8.4. Livestock Animals

9. Animal Pharmaceuticals Market, by End User

• 9.1. Introduction
• 9.2. Hospitals
• 9.3. Laboratories
• 9.4. Veternary Clinics

10. Americas Animal Pharmaceuticals Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Animal Pharmaceuticals Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Animal Pharmaceuticals Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Zoetis Enhances Feline Care with U.S. Launch of Bonqat Pregabalin Oral Solution
  • 13.3.2. Zoetis and Blacksmith Medicines Collaborate on Novel Antibiotics to Combat Resistant Bacteria and Enhance Animal Health
  • 13.3.3. Merck & Co. Bolsters Aquaculture Segment with Strategic Acquisition of Elanco's Aqua Business
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Alivira Animal Health Limited
• 2. Aurora Pharmaceutical, Inc.
• 3. Bimeda Holdings PLC
• 4. Boehringer Ingelheim International GmbH
• 5. Ceva Sante Animale
• 6. Dechra Pharmaceuticals PLC
• 7. Elanco Animal Health Incorporated
• 8. Hester Biosciences Limited
• 9. Huvepharma, Inc.
• 10. IDEXX Laboratories, Inc.
• 11. Indian Immunologicals Ltd.
• 12. Merck & Co., Inc.
• 13. Neogen Corp.
• 14. Nippon Zenyaku Kogyo Co., Ltd.
• 15. Norbrook Laboratories
• 16. Nutreco N.V.
• 17. Orion Corporation
• 18. Ourofino Saude Animal
• 19. Perrigo Company plc
• 20. PetIQ, LLC
• 21. Phibro Animal Health Corporation
• 22. Precision Science
• 23. Sanofi-Aventis Groupe S.A.
• 24. Vesper Group
• 25. Vetoquinol S.A.
• 26. Virbac S.A.
• 27. Zoetis Inc.